Cannara Biotech Inc logo

Cannara Biotech Inc

TSXV:LOVE (Canada)  
C$ 0.91 (-2.15%) Apr 12
9.46
P/B:
0.94
Market Cap:
C$ 81.92M ($ 59.46M)
Enterprise V:
C$ 127.93M ($ 92.86M)
Volume:
14.84K
Avg Vol (2M):
23.75K
Also Trade In:
Volume:
14.84K
Avg Vol (2M):
23.75K

Business Description

Description
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset 0.57
Debt-to-Equity 0.59
Debt-to-EBITDA 2.71
Interest Coverage 4.06
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.58
Distress
Grey
Safe
Beneish M-Score -1.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.24
9-Day RSI 49.3
14-Day RSI 48.48
6-1 Month Momentum % -6.73
12-1 Month Momentum % 21.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.37
Quick Ratio 0.72
Cash Ratio 0.12
Days Inventory 310.18
Days Sales Outstanding 48.6
Days Payable 123.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7
Shareholder Yield % -7.07

Financials

TSXV:LOVE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cannara Biotech Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 66.69
EPS (TTM) (C$) 0.09
Beta 0.1
Volatility % 48.43
14-Day RSI 48.48
14-Day ATR (C$) 0.042522
20-Day SMA (C$) 0.9195
12-1 Month Momentum % 21.25
52-Week Range (C$) 0.75 - 1.15
Shares Outstanding (Mil) 90.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cannara Biotech Inc Filings

Filing Date Document Date Form
No Filing Data

Cannara Biotech Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Cannara Biotech Inc Frequently Asked Questions

What is Cannara Biotech Inc(TSXV:LOVE)'s stock price today?
The current price of TSXV:LOVE is C$0.91. The 52 week high of TSXV:LOVE is C$1.15 and 52 week low is C$0.75.
When is next earnings date of Cannara Biotech Inc(TSXV:LOVE)?
The next earnings date of Cannara Biotech Inc(TSXV:LOVE) is .
Does Cannara Biotech Inc(TSXV:LOVE) pay dividends? If so, how much?
Cannara Biotech Inc(TSXV:LOVE) does not pay dividend.

Press Release

Subject Date
No Press Release